National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 8) (PB 85 of 2017) (Cth)

PB 85 of 2017

National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 8)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated         20^th October 2017

LISA LA RANCE

Assistant Secretary

Pricing and Policy Branch

Technology Assessment and Access Division

Department of Health

1          Name of Instrument

(1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 8).

(2)        This Instrument may also be cited as PB 85 of 2017.

2          Commencement

This Instrument commences on 1 November 2017.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1] Schedule 1, entry for Aciclovir in the form Tablet 200 mg [Pricing Quantity/Pack Quantity: 25]

omit from the column headed “Determined Price”:     7.13        substitute:             6.34

[2] Schedule 1, entry for Aciclovir in the form Tablet 200 mg [Pricing Quantity/Pack Quantity: 90]

omit from the column headed “Claimed Price”:          26.62     substitute:             23.67

[3] Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 2.5 mg

(a)   omit from the column headed “Determined Price”:             7.15        substitute:             6.28

(b)   omit from the column headed “Claimed Price”:                  13.38     substitute:             11.75

[4] Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg

(a)   omit from the column headed “Determined Price”:             8.94        substitute:             7.84

(b)   omit from the column headed “Claimed Price”:                  15.17     substitute:             13.30

[5] Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 10 mg

(a)   omit from the column headed “Determined Price”:             11.17     substitute:             9.80

(b)   omit from the column headed “Claimed Price”:                  17.40     substitute:             15.27

[6] Schedule 1, entry for Capecitabine

(a)   omit from the column headed “Determined Price”:             129.51   substitute:             93.40

(b)   omit from the column headed “Claimed Price”:                  135.99   substitute:             98.08

[7] Schedule 1, entry for Captopril in the form Tablet 12.5 mg

(a)   omit from the column headed “Determined Price”:             3.59        substitute:             3.12

(b)   omit from the column headed “Claimed Price”:                  7.26        substitute:             6.31

[8] Schedule 1, entry for Captopril in the form Tablet 25 mg [Brand: Capoten]

(a)   omit from the column headed “Determined Price”:             5.19        substitute:             4.51

(b)   omit from the column headed “Claimed Price”:                  10.18     substitute:             8.85

[9] Schedule 1, entry for Captopril in the form Tablet 25 mg [Brand: Zedace]

(a)   omit from the column headed “Determined Price”:             5.19        substitute:             4.51

(b)   omit from the column headed “Claimed Price”:                  8.86        substitute:             7.70

1. Schedule 1, entry for Captopril in the form Tablet 50 mg [Brand: Capoten]

(a)   omit from the column headed “Determined Price”:             10.24     substitute:             8.89

(b)   omit from the column headed “Claimed Price”:                  14.42     substitute:             12.52

1. Schedule 1, entry for Captopril in the form Tablet 50 mg [Brand: Zedace]

(a)   omit from the column headed “Determined Price”:             10.24     substitute:             8.89

(b)   omit from the column headed “Claimed Price”:                  13.91     substitute:             12.08

1. Schedule 1, entry for Citalopram

(a)   omit from the column headed “Determined Price”:             1.36        substitute:             1.21

(b)   omit from the column headed “Claimed Price”:                  8.15        substitute:             7.25

1. Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 50 mg [Pricing Quantity/Pack Quantity: 20]

(a)   omit from the column headed “Determined Price”:             14.90     substitute:             13.32

(b)   omit from the column headed “Claimed Price”:                  17.39     substitute:             15.55

1. Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 50 mg [Pricing Quantity/Pack Quantity: 50]

omit from the column headed “Claimed Price”:   38.43     substitute:             34.36

1. Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 100 mg

(a)   omit from the column headed “Determined Price”:             58.02     substitute:             51.88

(b)   omit from the column headed “Claimed Price”:                  59.48     substitute:             53.19

1. Schedule 1, entry for Donepezil in each of the forms: Tablet containing donepezil hydrochloride 5 mg; and Tablet containing
   donepezil hydrochloride 10 mg

(a)   omit from the column headed “Determined Price”:             11.45     substitute:             9.36

(b)   omit from the column headed “Claimed Price”:                  15.63     substitute:             12.78

1. Schedule 1, entry for Duloxetine in the form Capsule 30 mg (as hydrochloride)

(a)   omit from the column headed “Determined Price”:             4.62        substitute:             3.86

(b)   omit from the column headed “Claimed Price”:                  6.74        substitute:             5.63

1. Schedule 1, entry for Duloxetine in the form Capsule 60 mg (as hydrochloride)

(a)   omit from the column headed “Determined Price”:             6.60        substitute:             5.51

(b)   omit from the column headed “Claimed Price”:                  8.72        substitute:             7.28

1. Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 10 mg

(a)   omit from the column headed “Determined Price”:             3.21        substitute:             2.87

(b)   omit from the column headed “Claimed Price”:                  8.79        substitute:             7.86

1. Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 20 mg

(a)   omit from the column headed “Determined Price”:             4.09        substitute:             3.65

(b)   omit from the column headed “Claimed Price”:                  9.67        substitute:             8.63

1. Schedule 1, entry for Enalapril with Hydrochlorothiazide

(a)   omit from the column headed “Determined Price”:             5.66        substitute:             4.99

(b)   omit from the column headed “Claimed Price”:                  11.39     substitute:             10.04

1. Schedule 1, entry for Fluconazole

(a)   omit from the column headed “Determined Price”:             11.87     substitute:             9.90

(b)   omit from the column headed “Claimed Price”:                  15.14     substitute:             12.63

1. Schedule 1, entry for Indapamide in the form Tablet containing indapamide hemihydrate 1.5 mg

(a)   omit from the column headed “Form”:   1.5 mg                  substitute:             1.5 mg (sustained release)

(b)   omit from the column headed “Determined Price”:             8.10        substitute:             7.17

(c)   omit from the column headed “Claimed Price”:                  12.70     substitute:             11.24

1. Schedule 1, entry for Indapamide in the form Tablet containing indapamide hemihydrate 2.5 mg

(a)   omit from the column headed “Determined Price”:             5.55        substitute:             4.91

(b)   omit from the column headed “Claimed Price”:                  10.16     substitute:             8.99

1. Schedule 1, entry for Irbesartan in the form Tablet 75 mg [Brands: Avapro; Karvea]

(a)   omit from the column headed “Determined Price”:             1.34        substitute:             1.20

(b)   omit from the column headed “Claimed Price”:                  3.11        substitute:             2.79

1. Schedule 1, entry for Irbesartan in the form Tablet 150 mg [Brands: Avapro; Karvea]

(a)   omit from the column headed “Determined Price”:             1.91        substitute:             1.71

(b)   omit from the column headed “Claimed Price”:                  3.67        substitute:             3.29

1. Schedule 1, entry for Irbesartan in the form Tablet 300 mg [Brands: Avapro; Karvea]

(a)   omit from the column headed “Determined Price”:             3.82        substitute:             3.43

(b)   omit from the column headed “Claimed Price”:                  5.59        substitute:             5.02

1. Schedule 1, entry for Irbesartan with hydrochlorothiazide in the form Tablet 150 mg-12.5 mg [Brands: Avapro HCT 150/12.5;
   Karvezide 150/12.5]

(a)   omit from the column headed “Determined Price”:             2.19        substitute:             1.96

(b)   omit from the column headed “Claimed Price”:                  3.95        substitute:             3.54

1. Schedule 1, entry for Irbesartan with hydrochlorothiazide in the form Tablet 300 mg-12.5 mg [Brands: Avapro HCT 300/12.5;
   Karvezide 300/12.5]

(a)   omit from the column headed “Determined Price”:             4.02        substitute:             3.60

(b)   omit from the column headed “Claimed Price”:                  5.79        substitute:             5.18

1. Schedule 1, entry for Irbesartan with hydrochlorothiazide in the form Tablet 300 mg-25 mg [Brands: Avapro HCT 300/25;
   Karvezide 300/25]

(a)   omit from the column headed “Determined Price”:             4.38        substitute:             3.92

(b)   omit from the column headed “Claimed Price”:                  6.15        substitute:             5.50

1. Schedule 1, entry for Lamivudine

(a)   omit from the column headed “Determined Price”:             55.34     substitute:             34.70

(b)   omit from the column headed “Claimed Price”:                  56.30     substitute:             35.30

1. Schedule 1, entry for Lansoprazole in the form Tablet 15 mg (orally disintegrating)

(a)   omit from the column headed “Determined Price”:             3.52        substitute:             2.92

(b)   omit from the column headed “Claimed Price”:                  7.98        substitute:             6.62

1. Schedule 1, entry for Lansoprazole in the form Tablet 30 mg (orally disintegrating)

(a)   omit from the column headed “Determined Price”:             6.32        substitute:             5.24

(b)   omit from the column headed “Claimed Price”:                  10.79     substitute:             8.95

1. Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 10 mg

(a)   omit from the column headed “Determined Price”:             2.17        substitute:             1.95

(b)   omit from the column headed “Claimed Price”:                  5.03        substitute:             4.52

1. Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 20 mg

(a)   omit from the column headed “Determined Price”:             3.62        substitute:             3.25

(b)   omit from the column headed “Claimed Price”:                  6.48        substitute:             5.82

1. Schedule 1, entry for Levonorgestrel with Ethinyloestradiol in the form Pack containing 21 tablets 150 micrograms-30 micrograms
   and 7 inert tablets [Brand: Levlen ED]

(a)   omit from the column headed “Determined Price”:             6.39        substitute:             5.68

(b)   omit from the column headed “Claimed Price”:                  8.71        substitute:             7.74

1. Schedule 1, entry for Levonorgestrel with Ethinyloestradiol in the form Pack containing 21 tablets 150 micrograms-30 micrograms
   and 7 inert tablets [Brand: Microgynon 30 ED]

(a)   omit from the column headed “Determined Price”:             6.39        substitute:             5.68

(b)   omit from the column headed “Claimed Price”:                  15.83     substitute:             14.07

1. Schedule 1, entry for Levonorgestrel with Ethinyloestradiol in the form Pack containing 21 tablets 150 micrograms-30 micrograms
   and 7 inert tablets [Brand: Nordette 28]

(a)   omit from the column headed “Determined Price”:             6.39        substitute:             5.68

(b)   omit from the column headed “Claimed Price”:                  18.48     substitute:             16.43

1. Schedule 1, entry for Methylprednisolone

(a)   omit from the column headed “Determined Price”:             12.15     substitute:             10.58

(b)   omit from the column headed “Claimed Price”:                  14.94     substitute:             13.01

1. Schedule 1, entry for Nifedipine in the form Tablet 10 mg

(a)   omit from the column headed “Determined Price”:             5.20        substitute:             4.64

(b)   omit from the column headed “Claimed Price”:                  6.91        substitute:             6.17

1. Schedule 1, entry for Ondansetron in the form Wafer 4 mg [Pricing Quantity/Pack Quantity: 4]

(a)   omit from the column headed “Determined Price”:             4.17        substitute:             3.41

(b)   omit from the column headed “Claimed Price”:                  6.96        substitute:             5.69

1. Schedule 1, entry for Ondansetron in the form Wafer 4 mg [Pricing Quantity/Pack Quantity: 10]

omit from the column headed “Claimed Price”:   13.22     substitute:             10.81

1. Schedule 1, entry for Ondansetron in the form Wafer 8 mg [Pricing Quantity/Pack Quantity: 4]

(a)   omit from the column headed “Determined Price”:             6.54        substitute:             5.35

(b)   omit from the column headed “Claimed Price”:                  9.33        substitute:             7.63

1. Schedule 1, entry for Ondansetron in the form Wafer 8 mg [Pricing Quantity/Pack Quantity: 10]

omit from the column headed “Claimed Price”:   19.14     substitute:             15.66

1. Schedule 1, entry for Paroxetine

(a)   omit from the column headed “Determined Price”:             3.77        substitute:             3.18

(b)   omit from the column headed “Claimed Price”:                  6.62        substitute:             5.58

1. Schedule 1, entry for Perindopril in the form Tablet containing perindopril arginine 2.5 mg

(a)   omit from the column headed “Determined Price”:             1.70        substitute:             1.43

(b)   omit from the column headed “Claimed Price”:                  6.31        substitute:             5.31

1. Schedule 1, entry for Perindopril in the form Tablet containing perindopril arginine 5 mg

(a)   omit from the column headed “Determined Price”:             3.17        substitute:             2.66

(b)   omit from the column headed “Claimed Price”:                  7.77        substitute:             6.52

1. Schedule 1, entry for Perindopril in the form Tablet containing perindopril arginine 10 mg

(a)   omit from the column headed “Determined Price”:             4.85        substitute:             4.07

(b)   omit from the column headed “Claimed Price”:                  9.45        substitute:             7.93

1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 5 mg perindopril arginine with 5 mg amlodipine
   (as besylate)

(a)   omit from the column headed “Determined Price”:             4.00        substitute:             3.49

(b)   omit from the column headed “Claimed Price”:                  8.60        substitute:             7.50

1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 5 mg perindopril arginine with 10 mg amlodipine
   (as besylate)

(a)   omit from the column headed “Determined Price”:             4.64        substitute:             4.13

(b)   omit from the column headed “Claimed Price”:                  9.24        substitute:             8.22

1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 5 mg amlodipine
   (as besylate)

(a)   omit from the column headed “Determined Price”:             5.68        substitute:             4.90

(b)   omit from the column headed “Claimed Price”:                  10.29     substitute:             8.88

1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 10 mg amlodipine
   (as besylate)

(a)   omit from the column headed “Determined Price”:             6.32        substitute:             5.54

(b)   omit from the column headed “Claimed Price”:                  10.93     substitute:             9.58

1. Schedule 1, entry for Perindopril with indapamide in the form Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg

(a)   omit from the column headed “Determined Price”:             2.17        substitute:             1.84

(b)   omit from the column headed “Claimed Price”:                  6.77        substitute:             5.74

1. Schedule 1, entry for Perindopril with indapamide in the form Tablet containing perindopril arginine 5 mg with indapamide
   hemihydrate 1.25 mg

(a)   omit from the column headed “Determined Price”:             4.10        substitute:             3.48

(b)   omit from the column headed “Claimed Price”:                  8.71        substitute:             7.39

1. Schedule 1, entry for Perindopril with indapamide in the form Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg

(a)   omit from the column headed “Determined Price”:             4.10        substitute:             3.48

(b)   omit from the column headed “Claimed Price”:                  6.84        substitute:             5.81

1. Schedule 1, entry for Prochlorperazine

(a)   omit from the column headed “Determined Price”:             1.01        substitute:             0.90

(b)   omit from the column headed “Claimed Price”:                  3.80        substitute:             3.39

1. Schedule 1, entry for Rabeprazole in each of the forms: Tablet containing rabeprazole sodium 10 mg (enteric coated); and
   Tablet containing rabeprazole sodium 20 mg (enteric coated)

(a)   omit from the column headed “Determined Price”:             3.59        substitute:             2.83

(b)   omit from the column headed “Claimed Price”:                  8.25        substitute:             6.50

1. Schedule 1, entry for Simvastatin in the form Tablet 10 mg [Brands: Lipex 10; Zocor]

(a)   omit from the column headed “Determined Price”:             1.17        substitute:             1.04

(b)   omit from the column headed “Claimed Price”:                  6.75        substitute:             6.00

1. Schedule 1, entry for Simvastatin in the form Tablet 20 mg [Brands: Lipex 20; Zocor]

(a)   omit from the column headed “Determined Price”:             1.69        substitute:             1.51

(b)   omit from the column headed “Claimed Price”:                  7.27        substitute:             6.50

1. Schedule 1, entry for Simvastatin in the form Tablet 40 mg [Brands: Lipex 40; Zocor]

(a)   omit from the column headed “Determined Price”:             2.43        substitute:             2.17

(b)   omit from the column headed “Claimed Price”:                  8.01        substitute:             7.15

1. Schedule 1, entry for Simvastatin in the form Tablet 80 mg [Brands: Lipex 80; Zocor]

(a)   omit from the column headed “Determined Price”:             3.48        substitute:             3.10

(b)   omit from the column headed “Claimed Price”:                  12.31     substitute:             10.97

1. Schedule 1, entry for Sumatriptan in the form Tablet 50 mg (as succinate) [Pricing Quantity/Pack Quantity: 2]

(a)   omit from the column headed “Determined Price”:             2.69        substitute:             2.40

(b)   omit from the column headed “Claimed Price”:                  4.87        substitute:             4.35

1. Schedule 1, entry for Sumatriptan in the form Tablet 50 mg (as succinate) [Pricing Quantity/Pack Quantity: 4]

omit from the column headed “Claimed Price”:   9.75        substitute:             8.70

1. Schedule 1, entry for Sumatriptan in the form Tablet (fast disintegrating) 50 mg (as succinate) [Pricing Quantity/Pack Quantity: 2]

(a)   omit from the column headed “Determined Price”:             2.69        substitute:             2.40

(b)   omit from the column headed “Claimed Price”:                  4.87        substitute:             4.35

1. Schedule 1, entry for Sumatriptan in the form Tablet (fast disintegrating) 50 mg (as succinate) [Pricing Quantity/Pack Quantity: 4]

omit from the column headed “Claimed Price”:   9.75        substitute:             8.70

1. Schedule 1, entry for Telmisartan in the form Tablet 40 mg

(a)   omit from the column headed “Determined Price”:             2.50        substitute:             1.94

(b)   omit from the column headed “Claimed Price”:                  5.00        substitute:             3.88

1. Schedule 1, entry for Telmisartan in the form Tablet 80 mg

(a)   omit from the column headed “Determined Price”:             7.24        substitute:             5.61

(b)   omit from the column headed “Claimed Price”:                  9.74        substitute:             7.55

1. Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 40 mg-5 mg (as besylate)

(a)   omit from the column headed “Determined Price”:             3.27        substitute:             2.71

(b)   omit from the column headed “Claimed Price”:                  5.77        substitute:             4.78

1. Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 40 mg-10 mg (as besylate)

(a)   omit from the column headed “Determined Price”:             3.87        substitute:             3.31

(b)   omit from the column headed “Claimed Price”:                  6.37        substitute:             5.45

1. Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 80 mg-5 mg (as besylate)

(a)   omit from the column headed “Determined Price”:             8.01        substitute:             6.38

(b)   omit from the column headed “Claimed Price”:                  10.51     substitute:             8.37

1. Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 80 mg-10 mg (as besylate)

(a)   omit from the column headed “Determined Price”:             8.61        substitute:             6.98

(b)   omit from the column headed “Claimed Price”:                  11.11     substitute:             9.01

1. Schedule 1, entry for Valaciclovir [Pricing Quantity/Pack Quantity: 10]

(a)   omit from the column headed “Determined Price”:             5.24        substitute:             4.42

(b)   omit from the column headed “Claimed Price”:                  6.49        substitute:             5.47

1. Schedule 1, entry for Valaciclovir [Pricing Quantity/Pack Quantity: 30]

omit from the column headed “Claimed Price”:   18.21     substitute:             15.36

1. Schedule 1, entry for Valaciclovir [Pricing Quantity/Pack Quantity: 42]

omit from the column headed “Claimed Price”:   24.50     substitute:             20.67

1. Schedule 1, entry for Valaciclovir [Pricing Quantity/Pack Quantity: 100]

omit from the column headed “Claimed Price”:   52.92     substitute:             44.64

1. Schedule 1, entry for Zolmitriptan

(a)   omit from the column headed “Determined Price”:             7.04        substitute:             5.52

(b)   omit from the column headed “Claimed Price”:                  8.32        substitute:             6.52